1. Home
  2. GOSS vs KELYB Comparison

GOSS vs KELYB Comparison

Compare GOSS & KELYB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Gossamer Bio Inc.

GOSS

Gossamer Bio Inc.

HOLD

Current Price

$0.42

Market Cap

615.7M

Sector

Health Care

ML Signal

HOLD

Logo Kelly Services Inc. Class B

KELYB

Kelly Services Inc. Class B

BUY

Current Price

$16.52

Market Cap

513.9M

ML Signal

BUY

Company Overview

Basic Information
Metric
GOSS
KELYB
Founded
2015
1946
Country
United States
United States
Employees
N/A
5570
Industry
Biotechnology: Pharmaceutical Preparations
Professional Services
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
615.7M
513.9M
IPO Year
2018
N/A

Fundamental Metrics

Financial Performance
Metric
GOSS
KELYB
Price
$0.42
$16.52
Analyst Decision
Strong Buy
Analyst Count
7
0
Target Price
$8.83
N/A
AVG Volume (30 Days)
16.9M
109.6K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
2.30%
EPS Growth
78.81
N/A
EPS
N/A
N/A
Revenue
$114,701,000.00
N/A
Revenue This Year
N/A
$0.72
Revenue Next Year
$6.41
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.33
$8.38
52 Week High
$3.87
$125.00

Technical Indicators

Market Signals
Indicator
GOSS
KELYB
Relative Strength Index (RSI) 13.82 47.04
Support Level N/A N/A
Resistance Level $1.31 $16.33
Average True Range (ATR) 0.17 9.58
MACD -0.18 -0.80
Stochastic Oscillator 1.65 1.92

Price Performance

Historical Comparison
GOSS
KELYB

About GOSS Gossamer Bio Inc.

Gossamer Bio Inc is a clinical-stage biopharmaceutical company. It focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology. The company pipeline products include Seralutinib, which address the cellular overgrowth, fibrosis, and vascular remodeling which underlie PAH (pulmonary arterial hypertension); GB004, for the treatment of inflammatory bowel disease, including ulcerative colitis and Crohn's disease; GB1275, for the treatment of oncology indications; and GB001, for the treatment of moderate-to-severe eosinophilic asthma.

About KELYB Kelly Services Inc. Class B

Kelly Services Inc is a provider of workforce solutions and consulting, and staffing services to a diverse group of clients operating in the Americas, Europe, and the Asia-Pacific region across various industries. The company's reportable segments are: Enterprise Talent Management, Science, Engineering and Technology, and Education. Maximum revenue is generated from its Enterprise Talent Management segment, which delivers temporary staffing, outcome-based, and permanent placement services focused on light industrial, contact center, and office and clerical specialties in North America across various industries. It also provides talent supply chain and workforce talent solutions, including MSP, RPO, and PPO solutions to its clients. Geographically, it derives key revenue from the USA.

Share on Social Networks: